FCM
TMO icon

Fieldview Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Fieldview Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
+595
New +$286K 0.09% 381
2025
Q4 		– Sell
-10,497
Closed -$5.09M – 650
2025
Q3 		$5.09M Buy
+10,497
New +$4.89M 0.83% 13
2025
Q2 		– Sell
-6,499
Closed -$3.23M – 517
2025
Q1 		$3.23M Buy
6,499
+5,890
+967% +$3.19M 0.46% 72
2024
Q4 		$317K Buy
+609
New +$335K 0.05% 352

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fieldview Capital Management's TMO Position: Q2 2026 in Review

Fieldview Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 595 shares worth $298K. The stake represents 0.09% of the portfolio and ranks #381 among its holdings. This is a return to the name: Fieldview Capital Management previously reported a position in TMO as recently as Q3 2025.

Fieldview Capital Management first reported a position in TMO in Q4 2024 and has held it in 4 quarters since. The position peaked at $5.09M in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fieldview Capital Management held 595 shares of Thermo Fisher Scientific worth $298K as of Q2 2026.
  • Thermo Fisher Scientific was a new Fieldview Capital Management position in Q2 2026.
  • Thermo Fisher Scientific made up 0.09% of Fieldview Capital Management's portfolio in Q2 2026, its #381 holding.
  • Fieldview Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 4 quarters since.
  • Fieldview Capital Management's Thermo Fisher Scientific position peaked at $5.09M in Q3 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.